Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 21 5 2020
medline: 30 7 2020
entrez: 21 5 2020
Statut: ppublish

Résumé

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries.

Identifiants

pubmed: 32433015
doi: 10.3201/eid2608.201843
pmc: PMC7392437
doi:

Substances chimiques

Coronavirus Envelope Proteins 0
DNA Primers 0
DNA Probes 0
Reagent Kits, Diagnostic 0
Viral Envelope Proteins 0
envelope protein, SARS-CoV-2 0
RNA-Dependent RNA Polymerase EC 2.7.7.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1944-1946

Références

Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Euro Surveill. 2020 Feb;25(6):
pubmed: 32046815

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH